CVS vs SANA · P/E 16, rev $106.10B vs $846.0M cap
CVS Health Corp (CVS) versus Sana Biotechnology Inc (SANA) — a side-by-side from cached financials, not a winner call.
CVS Health Corp (CVS) is a healthcare plans company listed on US.
Sana Biotechnology Inc (SANA) is a biotechnology company listed on NASDAQ.
Latest reported CVS revenue for 2026-06-30 was $106.10B. Net income was $2.98B. Revenue was up 5.6% from 2026-03-31 to 2026-06-30. CVS currently screens at market cap $86.20B and trailing P/E 16.3.
SANA does not have a complete income-statement cache yet.
CVS currently screens at market cap $86.20B and trailing P/E 16.3. SANA currently screens at market cap $846.0M.
Not investment advice. Open the CVS and SANA stock pages for the full models.
Not investment advice.